What Comes Next in Biotech Translational Capital? Over the first half of 2012, there has been a lot of data and… August 1, 2012 Uncategorized
The Quarter is Over…And of course that means VC data The venture capital investment numbers are out for the Q2 2012 (courtesy of NVCA & PwC). Last… July 20, 2012 Equity financing
Walls and Fences – Biotechnology Analogy After the Biotechnology Industry Organization (BIO) international convention last week, I spent the weekend… June 26, 2012 Uncategorized
Pharma Strategy Blog, AACR and Ribonucleases The American Association for Cancer Research annual meeting has come and gone for 2012… May 3, 2012 Uncategorized
Learning from Shareholders This week we held our annual meeting for shareholders of Quintessence (private company funded… April 13, 2012 Uncategorized
A Biotech Fable – The Crows and the Pitcher In the old days, the birds didn’t worry about the narrow neck of the… March 20, 2012 Uncategorized
What do I know about GETTING a job? This summer I have had a number of conversations with scientists looking for jobs… September 6, 2011 Uncategorized
Are you ready to tell your story? This topic came to mind because I spent a considerable amount of time over… August 25, 2011 Uncategorized
Private Equity – Beyond Traditional Venture Capital In the biotech industry, there is a quote by that is often used to… July 1, 2011 Uncategorized